MedTrace Logo

Endovascular Therapy for Renal Artery Stenosis in China

NCT03080519 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5000

Last updated 2017-03-15

No results posted yet for this study

Summary

A multicenter prospective registry planned to recruit more than 5 000 patients with renal artery stenosis was carried out in China. This primary purpose of this study was to evaluate the safety and efficacy of renal artery revascularization in the real world. The secondary purpose was to investigate the etiologic distribution of renal artery stenosis and optimize the indications for renal artery revascularization.

Conditions

  • Renal Artery Obstruction
  • Hypertension, Renovascular

Interventions

PROCEDURE

Endovascular Therapy

Balloon angioplasty and stenting for renal artery stenosis

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    lead OTHER

Principal Investigators

  • Xiongjing Jiang, Dr. · Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-30
Primary Completion
2022-04-30
Completion
2024-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03080519 on ClinicalTrials.gov